Cargando…
Metabolic dysfunction-associated fatty liver disease and liver fibrosis score in patients with COVID-19 as predictors of adverse clinical outcomes: an artificial intelligent application through machine learning
Autores principales: | Dalbeni, A., Zoncapè, M., Carlin, M., Bicego, M., Simonetti, A., Ceruti, V., Mantovani, A., Inglese, F., Zamboni, G., Sartorio, A., Minuz, P., Romano, S., Crisafulli, E., Fava, C., Sacerdoti, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935166/ http://dx.doi.org/10.1016/j.dld.2022.01.045 |
Ejemplares similares
-
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application
por: Zoncapè, Mirko, et al.
Publicado: (2023) -
Platelets in Non-alcoholic Fatty Liver Disease
por: Dalbeni, Andrea, et al.
Publicado: (2022) -
Low testosterone levels predict clinical adverse outcomes in sars-cov-2 pneumonia patients
por: Rastrelli, Prof. Giulia, et al.
Publicado: (2022) -
Manifestations cliniques et facteurs pronostiques de la COVID-19 chez les patients souffrant de gliome diffus
por: Lozano, Fernando, et al.
Publicado: (2021) -
Encéphalite limbique post Covid-19 : étude d’un cas
por: Saidi, Karima, et al.
Publicado: (2022)